期刊目次

加入编委

期刊订阅

添加您的邮件地址以接收即将发行期刊数据:

Open Access Article

International Research in Chinese Medicine. 2022; 2: (4) ; 33-35 ; DOI: 10.12208/j.ircm.20220082.

Pharmacological Analysis of Sijunzi Decoction
四君子汤的药理作用分析

作者: 于淼 *

第962医院 黑龙江哈尔滨

*通讯作者: 于淼,单位:第9医院 黑龙江哈尔滨;

发布时间: 2022-12-27 总浏览量: 374

摘要

目的 探析四君子汤对脾胃气虚证的药理作用。方法 回顾性分析2020年10月-2021年10月间在我市医院接诊治疗的68例脾胃气虚证患者为研究对象,随机分为对照组(n=34,实施西药治疗)、观察组(n=34,应用四君子汤治疗)两组;比较两组患者的治疗效果,并且比较两组患者治疗14天后的复发情况。结果 观察组患者的治疗有效率97.06%(33/34)明显要高于对照组的治疗有效率85.29%(29/34),组间对比差异显著(P<0.05)。观察组患者治疗后的复发率0.00%(0/34)要显著低于对照组的复发率11.76%(4/34),数据比对差异不大(P<0.05)。结论 运用四君子汤治疗脾胃气虚证患者的效果显著,有效消除患者临床症状,提高治愈率,且复发率较低,提高患者的日常生活质量,具有较高的临床应用价值。

关键词: 四君子汤;脾胃气虚证;药理作用

Abstract

Objective: To explore the pharmacological effect of Sijunzi decoction on spleen stomach qi deficiency syndrome.
Methods: Retrospective analysis was made on 68 patients with spleen stomach qi deficiency treated in our hospital from October 2020 to October 2021, and randomly divided into two groups: the control group (n=34, treated with western medicine) and the observation group (n=34, treated with Sijunzi decoction); Compare the treatment effect of the two groups of patients, and compare the recurrence of the two groups of patients after 14 days of treatment.
Results: The effective rate of treatment in the observation group was 97.06% (33/34), which was significantly higher than that in the control group (85.29% (29/34), with significant difference between groups (P<0.05). The recurrence rate of patients in the observation group after treatment was 0.00% (0/34), which was significantly lower than that of patients in the control group (11.76% (4/34), and there was no significant difference in data comparison (P<0.05).
Conclusion  : Sijunzi decoction is effective in treating patients with spleen stomach qi deficiency syndrome, effectively eliminating the clinical symptoms of patients, improving the cure rate, and the recurrence rate is low, improving the quality of daily life of patients, with high clinical application value.

Key words: Sijunzi Decoction; Spleen stomach qi deficiency syndrome; pharmacological action

参考文献 References

[1] 姜海霞. 四君子汤在中医内科疾病脾胃气虚症中的应用分析[J]. 世界最新医学信息文摘(电子版), 2020, 020(005):171-172.

[2] 许汉明. 四君子汤治疗中医内科疾病脾胃气虚证临床分析[J]. 中医临床研究, 2018, 10(13):84-85.

[3] 李锡光. 四君子汤治疗中医内科疾病脾胃气虚证临床疗效分析[J]. 临床医药文献电子杂志, 2020,7(81):143-144.

[4] 尚如霞, 徐卫东, 许晓倩, et al. 四君子汤血清药效成分的HPLC-MS分析[J]. 江苏大学学报(医学版), 2018, 028(006):529-533.

[5] 葛韵芝, 许寅, 丁超. 基于网络药理学分析四君子汤治疗结直肠癌的作用机制[J]. 西部中医药, 2021, 34(8):84-90.

[6] 曹慧君. 四君子汤的药理作用[J]. 当代医药论丛, 2021,19(1):138-141.

[7] 高伟红. 中医内科疾病脾胃气虚证患者中采用四君子汤治疗的疗效分析[J]. 中国保健营养, 2018, 028(014):216-217.

[8] 李思彤. 四君子汤治疗脾胃气虚证的临床疗效[J]. 内蒙古中医药, 2020, 39(2):50-51.

[9] 刘琳, 李岩. 四君子汤对胃肠道药理作用的研究进展[J]. 医学综述, 2019, 25(5):990-994.

引用本文

于淼, 四君子汤的药理作用分析[J]. 国际中医药研究, 2022; 2: (4) : 33-35.